| 0 |
DYSKINESIA HYPERPYREXIA SYNDROME |
29 |
0.6170 |
| 1 |
PARKINSONISM HYPERPYREXIA SYNDROME |
43 |
0.2402 |
| 2 |
DOPAMINE DYSREGULATION SYNDROME |
47 |
0.1054 |
| 3 |
DEEP BRAIN STIMULATION |
61 |
0.1010 |
| 4 |
FREEZING PHENOMENON |
286 |
0.0772 |
| 5 |
DELUSION OF PARASITOSIS |
12 |
0.0764 |
| 6 |
STOMA SITE INDURATION |
9 |
0.0756 |
| 7 |
CATHETER SITE NODULE |
12 |
0.0628 |
| 8 |
RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER |
25 |
0.0622 |
| 9 |
ON AND OFF PHENOMENON |
343 |
0.0617 |
| 10 |
SPINAL CORD HAEMATOMA |
13 |
0.0607 |
| 11 |
STOMA SITE ODOUR |
13 |
0.0580 |
| 12 |
PARKINSONIAN REST TREMOR |
9 |
0.0476 |
| 13 |
STOMA SITE INFECTION |
59 |
0.0453 |
| 14 |
STOMA SITE ERYTHEMA |
84 |
0.0449 |
| 15 |
SOMATIC DELUSION |
11 |
0.0447 |
| 16 |
STOMA SITE HYPERGRANULATION |
28 |
0.0444 |
| 17 |
STOMA SITE OEDEMA |
9 |
0.0411 |
| 18 |
STOMA SITE PAIN |
59 |
0.0401 |
| 19 |
SALIVA DISCOLOURATION |
13 |
0.0389 |
| 20 |
STOMA SITE DISCHARGE |
106 |
0.0387 |
| 21 |
HYPERKINESIA |
82 |
0.0386 |
| 22 |
STOMA SITE REACTION |
24 |
0.0350 |
| 23 |
DEVICE COLOUR ISSUE |
14 |
0.0347 |
| 24 |
DUPLICATE THERAPY ERROR |
11 |
0.0343 |
| 25 |
STOMA SITE EXTRAVASATION |
13 |
0.0337 |
| 26 |
REDUCED FACIAL EXPRESSION |
34 |
0.0335 |
| 27 |
CATHETER SITE BRUISE |
11 |
0.0332 |
| 28 |
IMPULSE-CONTROL DISORDER |
66 |
0.0320 |
| 29 |
JEALOUS DELUSION |
9 |
0.0318 |
| 30 |
PARKINSONIAN GAIT |
19 |
0.0304 |
| 31 |
DYSKINESIA |
1114 |
0.0274 |
| 32 |
MORPHOEA |
13 |
0.0269 |
| 33 |
RESTING TREMOR |
17 |
0.0263 |
| 34 |
GAIT SPASTIC |
9 |
0.0262 |
| 35 |
STOMA COMPLICATION |
25 |
0.0246 |
| 36 |
LIVEDO RETICULARIS |
51 |
0.0244 |
| 37 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
11 |
0.0236 |
| 38 |
BASAL GANGLIA INFARCTION |
8 |
0.0233 |
| 39 |
BRADYKINESIA |
136 |
0.0230 |
| 40 |
INFUSION SITE NODULE |
22 |
0.0229 |
| 41 |
STOMA SITE INFLAMMATION |
17 |
0.0228 |
| 42 |
COMPULSIONS |
15 |
0.0225 |
| 43 |
SLEEP TALKING |
38 |
0.0224 |
| 44 |
STOMA SITE HAEMORRHAGE |
34 |
0.0221 |
| 45 |
STOMA SITE IRRITATION |
12 |
0.0221 |
| 46 |
HYPERSEXUALITY |
40 |
0.0219 |
| 47 |
HALLUCINATION, VISUAL |
461 |
0.0218 |
| 48 |
SOFT TISSUE MASS |
10 |
0.0216 |
| 49 |
CEREBRAL HYPOPERFUSION |
10 |
0.0215 |
| 50 |
INFUSION SITE CELLULITIS |
11 |
0.0208 |
| 51 |
AKINESIA |
43 |
0.0207 |
| 52 |
ILLUSION |
30 |
0.0181 |
| 53 |
HALLUCINATION |
1356 |
0.0180 |
| 54 |
CORNEAL OEDEMA |
40 |
0.0178 |
| 55 |
HALLUCINATIONS, MIXED |
74 |
0.0176 |
| 56 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
67 |
0.0173 |
| 57 |
COGWHEEL RIGIDITY |
18 |
0.0171 |
| 58 |
MALE SEXUAL DYSFUNCTION |
10 |
0.0167 |
| 59 |
RELAPSING-REMITTING MULTIPLE SCLEROSIS |
14 |
0.0162 |
| 60 |
YAWNING |
42 |
0.0157 |
| 61 |
MUSCLE RIGIDITY |
188 |
0.0157 |
| 62 |
DEMENTIA WITH LEWY BODIES |
17 |
0.0153 |
| 63 |
DRUG EFFECT VARIABLE |
17 |
0.0150 |
| 64 |
INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT |
15 |
0.0149 |
| 65 |
DEVICE ALARM ISSUE |
27 |
0.0149 |
| 66 |
CATHETER SITE RELATED REACTION |
11 |
0.0147 |
| 67 |
ACUTE PSYCHOSIS |
36 |
0.0145 |
| 68 |
MONOCYTE PERCENTAGE INCREASED |
10 |
0.0141 |
| 69 |
COMPULSIVE SHOPPING |
29 |
0.0141 |
| 70 |
REHABILITATION THERAPY |
52 |
0.0134 |
| 71 |
PSYCHOTIC SYMPTOM |
27 |
0.0131 |
| 72 |
POSTURE ABNORMAL |
42 |
0.0129 |
| 73 |
URINE LEUKOCYTE ESTERASE POSITIVE |
9 |
0.0129 |
| 74 |
STEREOTYPY |
12 |
0.0127 |
| 75 |
HYPORESPONSIVE TO STIMULI |
14 |
0.0119 |
| 76 |
DELUSION |
184 |
0.0118 |
| 77 |
DYSTONIA |
229 |
0.0118 |
| 78 |
NEUROLEPTIC MALIGNANT SYNDROME |
138 |
0.0116 |
| 79 |
DEVICE LOOSENING |
10 |
0.0116 |
| 80 |
PRODUCT RESIDUE PRESENT |
62 |
0.0115 |
| 81 |
BLADDER CATHETERISATION |
11 |
0.0114 |
| 82 |
GAZE PALSY |
19 |
0.0111 |
| 83 |
ALTERED VISUAL DEPTH PERCEPTION |
9 |
0.0110 |
| 84 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
32 |
0.0109 |
| 85 |
NONSPECIFIC REACTION |
58 |
0.0106 |
| 86 |
PROGRESSIVE MULTIPLE SCLEROSIS |
12 |
0.0104 |
| 87 |
MUTISM |
15 |
0.0103 |
| 88 |
DEVICE CONNECTION ISSUE |
20 |
0.0095 |
| 89 |
NEUROGENIC BLADDER |
20 |
0.0095 |
| 90 |
FRACTURED COCCYX |
12 |
0.0095 |
| 91 |
PERONEAL NERVE PALSY |
53 |
0.0093 |
| 92 |
DISORGANISED SPEECH |
17 |
0.0092 |
| 93 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
16 |
0.0092 |
| 94 |
PATHOLOGICAL GAMBLING |
15 |
0.0090 |
| 95 |
FINE MOTOR SKILL DYSFUNCTION |
26 |
0.0090 |
| 96 |
CATHETER SITE DISCHARGE |
10 |
0.0089 |
| 97 |
PERSECUTORY DELUSION |
22 |
0.0088 |
| 98 |
WHITE MATTER LESION |
11 |
0.0087 |
| 99 |
LUMBAR RADICULOPATHY |
10 |
0.0086 |
| 100 |
DEVICE OCCLUSION |
120 |
0.0085 |
| 101 |
DEVICE KINK |
31 |
0.0085 |
| 102 |
GAMBLING DISORDER |
22 |
0.0081 |
| 103 |
B-LYMPHOCYTE COUNT DECREASED |
11 |
0.0081 |
| 104 |
DISINHIBITION |
13 |
0.0081 |
| 105 |
LIVING IN RESIDENTIAL INSTITUTION |
15 |
0.0080 |
| 106 |
CATHETER SITE ERYTHEMA |
17 |
0.0079 |
| 107 |
DIZZINESS POSTURAL |
77 |
0.0079 |
| 108 |
INTENTIONAL UNDERDOSE |
58 |
0.0079 |
| 109 |
PARKINSONISM |
77 |
0.0079 |
| 110 |
WHEELCHAIR USER |
35 |
0.0079 |
| 111 |
DROOLING |
54 |
0.0078 |
| 112 |
INFUSION SITE IRRITATION |
10 |
0.0078 |
| 113 |
JC POLYOMAVIRUS TEST POSITIVE |
9 |
0.0077 |
| 114 |
ANTICHOLINERGIC SYNDROME |
12 |
0.0075 |
| 115 |
MUSCLE SPASTICITY |
91 |
0.0074 |
| 116 |
BALANCE DISORDER |
639 |
0.0074 |
| 117 |
HOSPICE CARE |
72 |
0.0073 |
| 118 |
NASAL DISCHARGE DISCOLOURATION |
10 |
0.0072 |
| 119 |
ORTHOSTATIC HYPOTENSION |
124 |
0.0071 |
| 120 |
SEIZURE LIKE PHENOMENA |
12 |
0.0071 |
| 121 |
MOTOR DYSFUNCTION |
71 |
0.0070 |
| 122 |
INFUSION SITE BRUISING |
15 |
0.0069 |
| 123 |
CATHETER SITE PAIN |
18 |
0.0069 |
| 124 |
IMPULSIVE BEHAVIOUR |
26 |
0.0069 |
| 125 |
SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS |
13 |
0.0069 |
| 126 |
CEREBRAL ATROPHY |
27 |
0.0068 |
| 127 |
INFUSION SITE INDURATION |
10 |
0.0067 |
| 128 |
PSYCHOTIC DISORDER |
192 |
0.0065 |
| 129 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
17 |
0.0065 |
| 130 |
GASTROSTOMY |
10 |
0.0064 |
| 131 |
JOINT INSTABILITY |
9 |
0.0064 |
| 132 |
SEROTONIN SYNDROME |
123 |
0.0064 |
| 133 |
MYOCLONUS |
76 |
0.0064 |
| 134 |
TONGUE BITING |
13 |
0.0063 |
| 135 |
URINARY HESITATION |
15 |
0.0063 |
| 136 |
SLOW SPEECH |
15 |
0.0062 |
| 137 |
DYSPHEMIA |
27 |
0.0062 |
| 138 |
WALKING AID USER |
40 |
0.0061 |
| 139 |
ABNORMAL SLEEP-RELATED EVENT |
8 |
0.0061 |
| 140 |
INFUSION SITE INFECTION |
14 |
0.0060 |
| 141 |
METABOLIC ENCEPHALOPATHY |
18 |
0.0060 |
| 142 |
THERAPEUTIC RESPONSE SHORTENED |
197 |
0.0059 |
| 143 |
PALLIATIVE CARE |
9 |
0.0059 |
| 144 |
HYPOKINESIA |
83 |
0.0057 |
| 145 |
CATATONIA |
30 |
0.0057 |
| 146 |
PARANOIA |
97 |
0.0056 |
| 147 |
GASTROINTESTINAL TUBE INSERTION |
14 |
0.0056 |
| 148 |
MULTIPLE SCLEROSIS RELAPSE |
381 |
0.0056 |
| 149 |
ABNORMAL DREAMS |
153 |
0.0055 |
| 150 |
IMMOBILE |
24 |
0.0055 |
| 151 |
FALL |
1821 |
0.0055 |
| 152 |
SPEECH DISORDER |
285 |
0.0054 |
| 153 |
CHOKING |
105 |
0.0054 |
| 154 |
URINE ANALYSIS ABNORMAL |
16 |
0.0053 |
| 155 |
PRE-EXISTING CONDITION IMPROVED |
33 |
0.0053 |
| 156 |
TORTICOLLIS |
11 |
0.0052 |
| 157 |
GAIT INABILITY |
172 |
0.0051 |
| 158 |
DEVICE POWER SOURCE ISSUE |
15 |
0.0051 |
| 159 |
PSYCHIATRIC DECOMPENSATION |
10 |
0.0051 |
| 160 |
DECUBITUS ULCER |
41 |
0.0050 |
| 161 |
INFUSION SITE REACTION |
15 |
0.0050 |
| 162 |
HYPERNATRAEMIA |
25 |
0.0050 |
| 163 |
MOBILITY DECREASED |
360 |
0.0050 |
| 164 |
BEHAVIOUR DISORDER |
27 |
0.0050 |
| 165 |
STARING |
12 |
0.0050 |
| 166 |
INCOHERENT |
32 |
0.0049 |
| 167 |
TREMOR |
819 |
0.0049 |
| 168 |
PNEUMOPERITONEUM |
9 |
0.0049 |
| 169 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
16 |
0.0048 |
| 170 |
GAIT DISTURBANCE |
922 |
0.0048 |
| 171 |
WHITE BLOOD CELLS URINE POSITIVE |
9 |
0.0048 |
| 172 |
SKIN LACERATION |
52 |
0.0048 |
| 173 |
POTENTIATING DRUG INTERACTION |
16 |
0.0048 |
| 174 |
CLUMSINESS |
13 |
0.0048 |
| 175 |
DYSSTASIA |
139 |
0.0048 |
| 176 |
STRIDOR |
14 |
0.0048 |
| 177 |
DELIRIUM |
165 |
0.0047 |
| 178 |
DECREASED INTEREST |
28 |
0.0047 |
| 179 |
EYE CONTUSION |
10 |
0.0047 |
| 180 |
HYPERSOMNIA |
133 |
0.0046 |
| 181 |
HALLUCINATION, AUDITORY |
73 |
0.0046 |
| 182 |
HYPERTHERMIA |
35 |
0.0046 |
| 183 |
HEAD INJURY |
145 |
0.0046 |
| 184 |
MULTIPLE SCLEROSIS |
219 |
0.0046 |
| 185 |
MOVEMENT DISORDER |
147 |
0.0046 |
| 186 |
DYSGRAPHIA |
30 |
0.0045 |
| 187 |
CATHETER SITE INFECTION |
17 |
0.0045 |
| 188 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
10 |
0.0045 |
| 189 |
GENERALISED TONIC-CLONIC SEIZURE |
74 |
0.0045 |
| 190 |
MICTURITION URGENCY |
51 |
0.0045 |
| 191 |
DEVICE USE ISSUE |
78 |
0.0045 |
| 192 |
MIDDLE INSOMNIA |
83 |
0.0044 |
| 193 |
UROSEPSIS |
41 |
0.0044 |
| 194 |
SKIN ABRASION |
21 |
0.0044 |
| 195 |
DEMENTIA |
123 |
0.0044 |
| 196 |
FAECALOMA |
24 |
0.0044 |
| 197 |
NOCTURIA |
53 |
0.0044 |
| 198 |
PNEUMONIA ASPIRATION |
108 |
0.0043 |
| 199 |
OBSESSIVE-COMPULSIVE DISORDER |
34 |
0.0042 |
| 200 |
BLADDER DISORDER |
42 |
0.0042 |
| 201 |
LOSS OF CONTROL OF LEGS |
16 |
0.0042 |
| 202 |
VOLVULUS |
10 |
0.0042 |
| 203 |
DRY MOUTH |
335 |
0.0041 |
| 204 |
ATROPHY |
8 |
0.0041 |
| 205 |
PROSTATOMEGALY |
16 |
0.0041 |
| 206 |
COGNITIVE DISORDER |
190 |
0.0041 |
| 207 |
INCONTINENCE |
43 |
0.0041 |
| 208 |
SLEEP TERROR |
17 |
0.0040 |
| 209 |
CONFUSIONAL STATE |
650 |
0.0040 |
| 210 |
SPUTUM DISCOLOURED |
38 |
0.0040 |
| 211 |
CATHETER SITE HAEMORRHAGE |
10 |
0.0040 |
| 212 |
LOGORRHOEA |
14 |
0.0040 |
| 213 |
INFUSION SITE HAEMORRHAGE |
13 |
0.0039 |
| 214 |
RIB FRACTURE |
81 |
0.0039 |
| 215 |
ASPIRATION |
43 |
0.0039 |
| 216 |
SEDATION COMPLICATION |
10 |
0.0039 |
| 217 |
INFUSION SITE ERYTHEMA |
33 |
0.0039 |
| 218 |
PRESCRIBED UNDERDOSE |
78 |
0.0039 |
| 219 |
NIGHTMARE |
135 |
0.0039 |
| 220 |
ANAL INCONTINENCE |
35 |
0.0039 |
| 221 |
MUSCLE TIGHTNESS |
63 |
0.0039 |
| 222 |
DYSARTHRIA |
146 |
0.0039 |
| 223 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
10 |
0.0038 |
| 224 |
MENTAL STATUS CHANGES |
106 |
0.0038 |
| 225 |
HYPERTONIC BLADDER |
11 |
0.0038 |
| 226 |
SENSORY DISTURBANCE |
61 |
0.0038 |
| 227 |
ATAXIA |
45 |
0.0038 |
| 228 |
CERVICAL VERTEBRAL FRACTURE |
13 |
0.0038 |
| 229 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
10 |
0.0038 |
| 230 |
PRODUCT CLEANING INADEQUATE |
10 |
0.0037 |
| 231 |
URINE ABNORMALITY |
17 |
0.0037 |
| 232 |
TRIGEMINAL NEURALGIA |
15 |
0.0037 |
| 233 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
17 |
0.0037 |
| 234 |
URINARY TRACT INFECTION |
632 |
0.0037 |
| 235 |
FACIAL PARESIS |
13 |
0.0037 |
| 236 |
HYPERTONIA |
21 |
0.0037 |
| 237 |
COMMUNICATION DISORDER |
14 |
0.0037 |
| 238 |
SOMNAMBULISM |
24 |
0.0037 |
| 239 |
HIP FRACTURE |
117 |
0.0036 |
| 240 |
HYPOPHAGIA |
93 |
0.0036 |
| 241 |
BLOOD IMMUNOGLOBULIN G DECREASED |
9 |
0.0036 |
| 242 |
DEVICE PLACEMENT ISSUE |
13 |
0.0036 |
| 243 |
PSYCHOMOTOR HYPERACTIVITY |
60 |
0.0036 |
| 244 |
INITIAL INSOMNIA |
37 |
0.0036 |
| 245 |
SALIVARY HYPERSECRETION |
36 |
0.0036 |
| 246 |
POOR QUALITY SLEEP |
76 |
0.0035 |
| 247 |
URINARY INCONTINENCE |
103 |
0.0035 |
| 248 |
JAW DISORDER |
19 |
0.0035 |
| 249 |
GENERAL SYMPTOM |
26 |
0.0035 |
| 250 |
SCREAMING |
22 |
0.0035 |
| 251 |
PARTIAL SEIZURES |
18 |
0.0034 |
| 252 |
DISORIENTATION |
136 |
0.0034 |
| 253 |
DEVICE DISLOCATION |
148 |
0.0034 |
| 254 |
CLAVICLE FRACTURE |
13 |
0.0034 |
| 255 |
MUSCULOSKELETAL STIFFNESS |
297 |
0.0034 |
| 256 |
SENSORY LOSS |
27 |
0.0034 |
| 257 |
AGGRESSION |
166 |
0.0033 |
| 258 |
DRUG EFFECT DELAYED |
15 |
0.0033 |
| 259 |
AGITATION |
242 |
0.0033 |
| 260 |
TENSION |
20 |
0.0033 |
| 261 |
THERAPY CESSATION |
168 |
0.0033 |
| 262 |
COORDINATION ABNORMAL |
45 |
0.0032 |
| 263 |
EYE MOVEMENT DISORDER |
22 |
0.0032 |
| 264 |
NEUROTOXICITY |
56 |
0.0032 |
| 265 |
MICTURITION DISORDER |
11 |
0.0032 |
| 266 |
SOMNOLENCE |
637 |
0.0032 |
| 267 |
TOXIC ENCEPHALOPATHY |
16 |
0.0032 |
| 268 |
HYPERREFLEXIA |
11 |
0.0032 |
| 269 |
DYSPHAGIA |
299 |
0.0031 |
| 270 |
SPINAL STENOSIS |
13 |
0.0031 |
| 271 |
APHASIA |
95 |
0.0031 |
| 272 |
THROMBOPHLEBITIS |
11 |
0.0031 |
| 273 |
VITAMIN B12 DECREASED |
9 |
0.0031 |
| 274 |
TIC |
17 |
0.0031 |
| 275 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
149 |
0.0031 |
| 276 |
PRESCRIBED OVERDOSE |
60 |
0.0031 |
| 277 |
SLEEP DISORDER |
217 |
0.0031 |
| 278 |
ESCHERICHIA URINARY TRACT INFECTION |
13 |
0.0031 |
| 279 |
NERVE COMPRESSION |
28 |
0.0030 |
| 280 |
MUSCULAR WEAKNESS |
344 |
0.0030 |
| 281 |
DIPLOPIA |
78 |
0.0030 |
| 282 |
DEVICE PHYSICAL PROPERTY ISSUE |
23 |
0.0030 |
| 283 |
HYPERAMMONAEMIA |
15 |
0.0030 |
| 284 |
HYPOMANIA |
11 |
0.0030 |
| 285 |
ENCEPHALOPATHY |
73 |
0.0030 |
| 286 |
ABNORMAL BEHAVIOUR |
117 |
0.0030 |
| 287 |
MALNUTRITION |
33 |
0.0029 |
| 288 |
LYMPHOCYTE COUNT DECREASED |
52 |
0.0029 |
| 289 |
BENIGN PROSTATIC HYPERPLASIA |
15 |
0.0029 |
| 290 |
TRISMUS |
15 |
0.0029 |
| 291 |
UNRESPONSIVE TO STIMULI |
74 |
0.0029 |
| 292 |
SEDATION |
75 |
0.0029 |
| 293 |
DEPRESSED MOOD |
151 |
0.0029 |
| 294 |
URINARY RETENTION |
95 |
0.0028 |
| 295 |
NYSTAGMUS |
15 |
0.0028 |
| 296 |
DEVICE ISSUE |
253 |
0.0028 |
| 297 |
FLUID INTAKE REDUCED |
14 |
0.0028 |
| 298 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
23 |
0.0028 |
| 299 |
BRUXISM |
15 |
0.0028 |
| 300 |
RESTLESS LEGS SYNDROME |
50 |
0.0027 |
| 301 |
SCOLIOSIS |
17 |
0.0027 |
| 302 |
FOOD INTOLERANCE |
10 |
0.0027 |
| 303 |
FORMICATION |
19 |
0.0027 |
| 304 |
TEMPERATURE INTOLERANCE |
28 |
0.0027 |
| 305 |
FEEDING DISORDER |
55 |
0.0027 |
| 306 |
MEMORY IMPAIRMENT |
372 |
0.0027 |
| 307 |
INFUSION SITE SWELLING |
17 |
0.0027 |
| 308 |
CENTRAL NERVOUS SYSTEM LESION |
37 |
0.0027 |
| 309 |
LYMPHOPENIA |
38 |
0.0027 |
| 310 |
SUBDURAL HAEMATOMA |
38 |
0.0027 |
| 311 |
SLUGGISHNESS |
27 |
0.0026 |
| 312 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
188 |
0.0026 |
| 313 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
12 |
0.0026 |
| 314 |
OPTIC NEURITIS |
24 |
0.0026 |
| 315 |
CONSTIPATION |
570 |
0.0026 |
| 316 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
9 |
0.0026 |
| 317 |
FRUSTRATION TOLERANCE DECREASED |
21 |
0.0026 |
| 318 |
INTERVERTEBRAL DISC DISORDER |
11 |
0.0026 |
| 319 |
MUSCULOSKELETAL DISORDER |
49 |
0.0026 |
| 320 |
RESTLESSNESS |
94 |
0.0026 |
| 321 |
PELVIC FRACTURE |
20 |
0.0026 |
| 322 |
TEARFULNESS |
11 |
0.0026 |
| 323 |
PETIT MAL EPILEPSY |
13 |
0.0025 |
| 324 |
BLOOD PRESSURE FLUCTUATION |
61 |
0.0025 |
| 325 |
CHOKING SENSATION |
14 |
0.0025 |
| 326 |
COLITIS MICROSCOPIC |
12 |
0.0025 |
| 327 |
APPENDICECTOMY |
9 |
0.0025 |
| 328 |
MANIA |
41 |
0.0025 |
| 329 |
INGUINAL HERNIA |
15 |
0.0025 |
| 330 |
VENTRICULAR ARRHYTHMIA |
9 |
0.0025 |
| 331 |
CONCUSSION |
19 |
0.0025 |
| 332 |
PRODUCT DOSE OMISSION |
160 |
0.0024 |
| 333 |
LEUKOCYTOSIS |
44 |
0.0024 |
| 334 |
HEMIPARESIS |
41 |
0.0024 |
| 335 |
RED CELL DISTRIBUTION WIDTH INCREASED |
10 |
0.0024 |
| 336 |
SEIZURE |
278 |
0.0024 |
| 337 |
SKIN MASS |
16 |
0.0024 |
| 338 |
SNORING |
9 |
0.0024 |
| 339 |
FACE INJURY |
9 |
0.0024 |
| 340 |
PERIPHERAL SWELLING |
364 |
0.0024 |
| 341 |
MUSCLE FATIGUE |
10 |
0.0024 |
| 342 |
BEDRIDDEN |
31 |
0.0024 |
| 343 |
ENDOCARDITIS |
12 |
0.0023 |
| 344 |
TARDIVE DYSKINESIA |
65 |
0.0023 |
| 345 |
MUSCLE TWITCHING |
53 |
0.0023 |
| 346 |
SPINAL OPERATION |
28 |
0.0023 |
| 347 |
SOCIAL AVOIDANT BEHAVIOUR |
13 |
0.0022 |
| 348 |
TERMINAL STATE |
15 |
0.0022 |
| 349 |
BLEPHAROSPASM |
14 |
0.0022 |
| 350 |
HYPOVOLAEMIA |
13 |
0.0022 |
| 351 |
EMBEDDED DEVICE |
22 |
0.0022 |
| 352 |
URINARY TRACT DISORDER |
10 |
0.0022 |
| 353 |
HOMICIDAL IDEATION |
9 |
0.0022 |
| 354 |
DISTURBANCE IN ATTENTION |
119 |
0.0022 |
| 355 |
CYSTITIS |
70 |
0.0022 |
| 356 |
GOITRE |
9 |
0.0022 |
| 357 |
LIMB DISCOMFORT |
68 |
0.0022 |
| 358 |
DEMYELINATION |
9 |
0.0022 |
| 359 |
INSOMNIA |
579 |
0.0022 |
| 360 |
PSYCHIATRIC SYMPTOM |
16 |
0.0022 |
| 361 |
CONDITION AGGRAVATED |
658 |
0.0022 |
| 362 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
19 |
0.0021 |
| 363 |
THERAPEUTIC RESPONSE UNEXPECTED |
96 |
0.0021 |
| 364 |
NEURALGIA |
52 |
0.0021 |
| 365 |
UNEVALUABLE EVENT |
161 |
0.0021 |
| 366 |
HYPERPYREXIA |
9 |
0.0021 |
| 367 |
PRODUCT DISPENSING ISSUE |
9 |
0.0021 |
| 368 |
BOWEL MOVEMENT IRREGULARITY |
16 |
0.0021 |
| 369 |
SUBCUTANEOUS ABSCESS |
10 |
0.0021 |
| 370 |
FOOT DEFORMITY |
23 |
0.0021 |
| 371 |
GASTROINTESTINAL MOTILITY DISORDER |
11 |
0.0021 |
| 372 |
VITAMIN D DEFICIENCY |
20 |
0.0020 |
| 373 |
SPINAL OSTEOARTHRITIS |
18 |
0.0020 |
| 374 |
FEELING OF BODY TEMPERATURE CHANGE |
12 |
0.0020 |
| 375 |
THINKING ABNORMAL |
38 |
0.0020 |
| 376 |
AFFECTIVE DISORDER |
16 |
0.0020 |
| 377 |
LETHARGY |
117 |
0.0020 |
| 378 |
HIP SURGERY |
11 |
0.0020 |
| 379 |
PULMONARY THROMBOSIS |
22 |
0.0020 |
| 380 |
INFUSION SITE PAIN |
26 |
0.0020 |
| 381 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
10 |
0.0020 |
| 382 |
WRIST FRACTURE |
24 |
0.0020 |
| 383 |
CONTUSION |
192 |
0.0020 |
| 384 |
FEELING JITTERY |
38 |
0.0020 |
| 385 |
BRADYPHRENIA |
13 |
0.0020 |
| 386 |
JOINT DISLOCATION |
21 |
0.0020 |
| 387 |
TROPONIN INCREASED |
15 |
0.0020 |
| 388 |
MACULAR OEDEMA |
11 |
0.0020 |
| 389 |
BLOOD PRESSURE ABNORMAL |
39 |
0.0020 |
| 390 |
DRUG EFFECT LESS THAN EXPECTED |
29 |
0.0020 |
| 391 |
NEUTROPHIL COUNT INCREASED |
20 |
0.0020 |
| 392 |
DEPRESSION |
444 |
0.0019 |
| 393 |
NEPHROGENIC ANAEMIA |
9 |
0.0019 |
| 394 |
BREAST MASS |
13 |
0.0019 |
| 395 |
DIZZINESS |
962 |
0.0019 |
| 396 |
FAILURE TO THRIVE |
10 |
0.0019 |
| 397 |
VENTRICULAR EXTRASYSTOLES |
20 |
0.0019 |
| 398 |
POLYNEUROPATHY |
23 |
0.0019 |
| 399 |
UPPER LIMB FRACTURE |
38 |
0.0019 |
| 400 |
MENTAL IMPAIRMENT |
46 |
0.0019 |
| 401 |
GASTROINTESTINAL INFECTION |
17 |
0.0019 |
| 402 |
DRUG INTERACTION |
300 |
0.0019 |
| 403 |
FACIAL PARALYSIS |
16 |
0.0019 |
| 404 |
JOINT INJURY |
40 |
0.0019 |
| 405 |
DEVICE BREAKAGE |
76 |
0.0019 |
| 406 |
DRY THROAT |
19 |
0.0019 |
| 407 |
FOOD POISONING |
10 |
0.0019 |
| 408 |
WITHDRAWAL SYNDROME |
78 |
0.0019 |
| 409 |
CARDIAC FLUTTER |
12 |
0.0019 |
| 410 |
EUPHORIC MOOD |
19 |
0.0019 |
| 411 |
DYSPHONIA |
108 |
0.0018 |
| 412 |
HAND FRACTURE |
13 |
0.0018 |
| 413 |
POLYURIA |
15 |
0.0018 |
| 414 |
SMALL INTESTINAL OBSTRUCTION |
22 |
0.0018 |
| 415 |
MAJOR DEPRESSION |
13 |
0.0018 |
| 416 |
POLLAKIURIA |
74 |
0.0018 |
| 417 |
GENERAL PHYSICAL HEALTH DETERIORATION |
205 |
0.0018 |
| 418 |
ACUTE RESPIRATORY FAILURE |
34 |
0.0018 |
| 419 |
ASTHENIA |
663 |
0.0018 |
| 420 |
HIP ARTHROPLASTY |
27 |
0.0018 |
| 421 |
VITAMIN D DECREASED |
15 |
0.0018 |
| 422 |
HYPOAESTHESIA |
260 |
0.0017 |
| 423 |
LOSS OF CONSCIOUSNESS |
221 |
0.0017 |
| 424 |
AMNESIA |
112 |
0.0017 |
| 425 |
URINE ODOUR ABNORMAL |
10 |
0.0017 |
| 426 |
ABASIA |
42 |
0.0017 |
| 427 |
ENERGY INCREASED |
10 |
0.0017 |
| 428 |
INTERVERTEBRAL DISC PROTRUSION |
37 |
0.0017 |
| 429 |
APHTHOUS ULCER |
13 |
0.0017 |
| 430 |
VISUAL FIELD DEFECT |
12 |
0.0017 |
| 431 |
NEPHROLITHIASIS |
76 |
0.0017 |
| 432 |
DEHYDRATION |
221 |
0.0017 |
| 433 |
FEELING ABNORMAL |
397 |
0.0017 |
| 434 |
DEVICE LEAKAGE |
71 |
0.0016 |
| 435 |
INJECTION SITE NODULE |
18 |
0.0016 |
| 436 |
POSTOPERATIVE WOUND INFECTION |
11 |
0.0016 |
| 437 |
SEXUAL DYSFUNCTION |
19 |
0.0016 |
| 438 |
LIMB INJURY |
44 |
0.0016 |
| 439 |
ARTHROPOD BITE |
12 |
0.0016 |
| 440 |
MUSCLE STRAIN |
14 |
0.0016 |
| 441 |
LIGAMENT SPRAIN |
16 |
0.0016 |
| 442 |
TACHYPNOEA |
22 |
0.0016 |
| 443 |
FEELING COLD |
45 |
0.0016 |
| 444 |
MOOD ALTERED |
44 |
0.0016 |
| 445 |
AKATHISIA |
22 |
0.0016 |
| 446 |
PRODUCT DOSE OMISSION ISSUE |
471 |
0.0016 |
| 447 |
ANXIETY |
454 |
0.0016 |
| 448 |
GROIN PAIN |
14 |
0.0016 |
| 449 |
GRIP STRENGTH DECREASED |
14 |
0.0016 |
| 450 |
HICCUPS |
13 |
0.0016 |
| 451 |
HEAD DISCOMFORT |
28 |
0.0016 |
| 452 |
BLOOD PRESSURE DECREASED |
105 |
0.0016 |
| 453 |
VISUAL IMPAIRMENT |
195 |
0.0016 |
| 454 |
HYPERHIDROSIS |
202 |
0.0016 |
| 455 |
THERAPY NON-RESPONDER |
70 |
0.0016 |
| 456 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
18 |
0.0016 |
| 457 |
DIVERTICULUM |
11 |
0.0015 |
| 458 |
ADVERSE DRUG REACTION |
139 |
0.0015 |
| 459 |
OEDEMA PERIPHERAL |
188 |
0.0015 |
| 460 |
PANIC ATTACK |
56 |
0.0015 |
| 461 |
REFUSAL OF TREATMENT BY PATIENT |
10 |
0.0015 |
| 462 |
NERVOUSNESS |
80 |
0.0015 |
| 463 |
ELECTROCARDIOGRAM ABNORMAL |
12 |
0.0015 |
| 464 |
PRESYNCOPE |
37 |
0.0015 |
| 465 |
BLOOD LACTIC ACID INCREASED |
8 |
0.0015 |
| 466 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
68 |
0.0015 |
| 467 |
GRAND MAL CONVULSION |
14 |
0.0015 |
| 468 |
NASAL DISCOMFORT |
12 |
0.0015 |
| 469 |
RHABDOMYOLYSIS |
63 |
0.0015 |
| 470 |
PERSONALITY CHANGE |
14 |
0.0015 |
| 471 |
TREATMENT NONCOMPLIANCE |
82 |
0.0015 |
| 472 |
MENINGITIS |
10 |
0.0015 |
| 473 |
MUSCLE SPASMS |
274 |
0.0015 |
| 474 |
LACERATION |
14 |
0.0015 |
| 475 |
FEELING DRUNK |
11 |
0.0015 |
| 476 |
WEIGHT DECREASED |
411 |
0.0015 |
| 477 |
VISION BLURRED |
201 |
0.0015 |
| 478 |
UNDERDOSE |
106 |
0.0015 |
| 479 |
SPINAL COMPRESSION FRACTURE |
12 |
0.0014 |
| 480 |
SPINAL PAIN |
17 |
0.0014 |
| 481 |
COMPLICATION ASSOCIATED WITH DEVICE |
21 |
0.0014 |
| 482 |
SECRETION DISCHARGE |
18 |
0.0014 |
| 483 |
FATIGUE |
1118 |
0.0014 |
| 484 |
DEFAECATION URGENCY |
10 |
0.0014 |
| 485 |
OCULAR DISCOMFORT |
16 |
0.0014 |
| 486 |
BLOOD URINE PRESENT |
27 |
0.0014 |
| 487 |
SCRATCH |
15 |
0.0014 |
| 488 |
CELLULITIS |
71 |
0.0014 |
| 489 |
SINUS TACHYCARDIA |
20 |
0.0014 |
| 490 |
MYDRIASIS |
18 |
0.0014 |
| 491 |
GLAUCOMA |
27 |
0.0014 |
| 492 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
24 |
0.0014 |
| 493 |
PARALYSIS |
20 |
0.0014 |
| 494 |
ALTERED STATE OF CONSCIOUSNESS |
30 |
0.0014 |
| 495 |
TONGUE DISORDER |
10 |
0.0014 |
| 496 |
COUGH |
387 |
0.0014 |
| 497 |
POLYP |
9 |
0.0014 |
| 498 |
BODY TEMPERATURE INCREASED |
28 |
0.0014 |
| 499 |
APATHY |
20 |
0.0014 |
| 500 |
WOUND INFECTION |
15 |
0.0014 |
| 501 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
75 |
0.0014 |
| 502 |
DYSURIA |
50 |
0.0014 |
| 503 |
ADVERSE REACTION |
18 |
0.0014 |
| 504 |
COVID-19 PNEUMONIA |
16 |
0.0014 |
| 505 |
SPINAL FRACTURE |
27 |
0.0013 |
| 506 |
HYPOTENSION |
269 |
0.0013 |
| 507 |
CEREBRAL HAEMORRHAGE |
48 |
0.0013 |
| 508 |
GASTROENTERITIS VIRAL |
24 |
0.0013 |
| 509 |
SKIN DISCOLOURATION |
61 |
0.0013 |
| 510 |
VITREOUS FLOATERS |
13 |
0.0013 |
| 511 |
THERAPY CHANGE |
13 |
0.0013 |
| 512 |
DRUG EFFECT INCOMPLETE |
48 |
0.0013 |
| 513 |
KNEE OPERATION |
13 |
0.0013 |
| 514 |
SCIATICA |
21 |
0.0013 |
| 515 |
CHOLECYSTECTOMY |
15 |
0.0013 |
| 516 |
ANOSMIA |
19 |
0.0013 |
| 517 |
PERIPHERAL COLDNESS |
18 |
0.0013 |
| 518 |
RESPIRATION ABNORMAL |
9 |
0.0013 |
| 519 |
TRANSIENT ISCHAEMIC ATTACK |
44 |
0.0013 |
| 520 |
ENCEPHALITIS |
9 |
0.0013 |
| 521 |
LARGE INTESTINE POLYP |
9 |
0.0013 |
| 522 |
PARAESTHESIA |
204 |
0.0013 |
| 523 |
BRAIN INJURY |
13 |
0.0013 |
| 524 |
PRODUCT DISTRIBUTION ISSUE |
12 |
0.0013 |
| 525 |
ANKLE FRACTURE |
20 |
0.0013 |
| 526 |
EXTRAPYRAMIDAL DISORDER |
32 |
0.0013 |
| 527 |
SARS-COV-2 TEST POSITIVE |
17 |
0.0013 |
| 528 |
MENTAL DISORDER |
56 |
0.0013 |
| 529 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
37 |
0.0013 |
| 530 |
CHROMATURIA |
29 |
0.0013 |
| 531 |
THERAPY PARTIAL RESPONDER |
20 |
0.0013 |
| 532 |
BRAIN FOG |
20 |
0.0013 |
| 533 |
PHOTOPHOBIA |
24 |
0.0013 |
| 534 |
PRODUCT ADMINISTRATION INTERRUPTED |
10 |
0.0013 |
| 535 |
KIDNEY INFECTION |
25 |
0.0013 |
| 536 |
BLOOD SODIUM DECREASED |
24 |
0.0013 |
| 537 |
STAPHYLOCOCCAL INFECTION |
42 |
0.0013 |
| 538 |
PRODUCT DOSE OMISSION IN ERROR |
36 |
0.0013 |
| 539 |
OSTEOMYELITIS |
23 |
0.0013 |
| 540 |
RESPIRATORY DISTRESS |
35 |
0.0013 |
| 541 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
13 |
0.0013 |
| 542 |
HAEMATOCRIT DECREASED |
25 |
0.0013 |
| 543 |
HYPERLIPIDAEMIA |
15 |
0.0013 |
| 544 |
COLD SWEAT |
22 |
0.0012 |
| 545 |
INTESTINAL OBSTRUCTION |
47 |
0.0012 |
| 546 |
FLUSHING |
126 |
0.0012 |
| 547 |
PRODUCT PHYSICAL ISSUE |
25 |
0.0012 |
| 548 |
FAECES SOFT |
9 |
0.0012 |
| 549 |
UTERINE LEIOMYOMA |
9 |
0.0012 |
| 550 |
POST PROCEDURAL INFECTION |
10 |
0.0012 |
| 551 |
FEELING HOT |
75 |
0.0012 |
| 552 |
ORAL DISCOMFORT |
17 |
0.0012 |
| 553 |
SENSITIVE SKIN |
9 |
0.0012 |
| 554 |
SYNCOPE |
122 |
0.0012 |
| 555 |
NECK PAIN |
68 |
0.0012 |
| 556 |
FOOT FRACTURE |
23 |
0.0012 |
| 557 |
THROAT IRRITATION |
54 |
0.0012 |
| 558 |
ILL-DEFINED DISORDER |
73 |
0.0012 |
| 559 |
BACK PAIN |
279 |
0.0012 |
| 560 |
WHITE BLOOD CELL COUNT INCREASED |
46 |
0.0012 |
| 561 |
LOWER LIMB FRACTURE |
23 |
0.0012 |
| 562 |
HEART RATE DECREASED |
42 |
0.0012 |
| 563 |
BIPOLAR DISORDER |
13 |
0.0012 |
| 564 |
CATARACT |
71 |
0.0012 |
| 565 |
INTERVERTEBRAL DISC DEGENERATION |
11 |
0.0012 |
| 566 |
CRYING |
43 |
0.0012 |
| 567 |
TOOTH FRACTURE |
13 |
0.0012 |
| 568 |
ABNORMAL LOSS OF WEIGHT |
8 |
0.0012 |
| 569 |
TACHYCARDIA |
104 |
0.0012 |
| 570 |
SQUAMOUS CELL CARCINOMA |
11 |
0.0012 |
| 571 |
FEMUR FRACTURE |
36 |
0.0012 |
| 572 |
LOCALISED INFECTION |
28 |
0.0012 |
| 573 |
COVID-19 |
203 |
0.0012 |
| 574 |
SLEEP APNOEA SYNDROME |
22 |
0.0012 |
| 575 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
11 |
0.0012 |
| 576 |
STATUS EPILEPTICUS |
13 |
0.0011 |
| 577 |
HEART RATE IRREGULAR |
26 |
0.0011 |
| 578 |
BRADYCARDIA |
61 |
0.0011 |
| 579 |
AFFECT LABILITY |
11 |
0.0011 |
| 580 |
HAEMORRHAGE INTRACRANIAL |
17 |
0.0011 |
| 581 |
HOSPITALISATION |
174 |
0.0011 |
| 582 |
VERTIGO |
69 |
0.0011 |
| 583 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
20 |
0.0011 |
| 584 |
HYPERTENSION |
239 |
0.0011 |
| 585 |
DECREASED IMMUNE RESPONSIVENESS |
11 |
0.0011 |
| 586 |
THIRST |
20 |
0.0011 |
| 587 |
HYPONATRAEMIA |
63 |
0.0011 |
| 588 |
RASH MACULAR |
39 |
0.0011 |
| 589 |
IRRITABILITY |
67 |
0.0011 |
| 590 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
44 |
0.0011 |
| 591 |
HYPOCALCAEMIA |
21 |
0.0011 |
| 592 |
DEVICE RELATED INFECTION |
17 |
0.0011 |
| 593 |
MUSCULOSKELETAL DISCOMFORT |
19 |
0.0011 |
| 594 |
HYPERAESTHESIA |
9 |
0.0011 |
| 595 |
POST PROCEDURAL COMPLICATION |
21 |
0.0011 |
| 596 |
UPPER-AIRWAY COUGH SYNDROME |
9 |
0.0011 |
| 597 |
ADVERSE EVENT |
100 |
0.0011 |
| 598 |
SUICIDAL IDEATION |
99 |
0.0011 |
| 599 |
EOSINOPHIL COUNT INCREASED |
9 |
0.0011 |
| 600 |
INJECTION SITE INDURATION |
14 |
0.0011 |
| 601 |
FEAR |
29 |
0.0011 |
| 602 |
PNEUMOTHORAX |
17 |
0.0011 |
| 603 |
SCHIZOPHRENIA |
13 |
0.0011 |
| 604 |
SEPSIS |
119 |
0.0011 |
| 605 |
PALLOR |
29 |
0.0011 |
| 606 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
21 |
0.0011 |
| 607 |
PNEUMONIA |
343 |
0.0011 |
| 608 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
30 |
0.0011 |
| 609 |
PRODUCT DISPENSING ERROR |
23 |
0.0011 |
| 610 |
PRODUCT PRESCRIBING ISSUE |
23 |
0.0011 |
| 611 |
IMPAIRED DRIVING ABILITY |
12 |
0.0011 |
| 612 |
INTERNAL HAEMORRHAGE |
12 |
0.0010 |
| 613 |
CYST |
13 |
0.0010 |
| 614 |
KNEE ARTHROPLASTY |
22 |
0.0010 |
| 615 |
DEVICE DIFFICULT TO USE |
69 |
0.0010 |
| 616 |
DEATH |
898 |
0.0010 |
| 617 |
HAEMATOMA |
27 |
0.0010 |
| 618 |
HYSTERECTOMY |
9 |
0.0010 |
| 619 |
PYELONEPHRITIS |
9 |
0.0010 |
| 620 |
MALAISE |
455 |
0.0010 |
| 621 |
CHOLELITHIASIS |
34 |
0.0010 |
| 622 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
9 |
0.0010 |
| 623 |
DECREASED APPETITE |
240 |
0.0010 |
| 624 |
CONVULSION |
59 |
0.0010 |
| 625 |
BLOOD POTASSIUM DECREASED |
31 |
0.0010 |
| 626 |
BODY HEIGHT DECREASED |
11 |
0.0010 |
| 627 |
RESPIRATORY FAILURE |
74 |
0.0010 |
| 628 |
OSTEOARTHRITIS |
43 |
0.0010 |
| 629 |
EPILEPSY |
31 |
0.0010 |
| 630 |
TOXICITY TO VARIOUS AGENTS |
171 |
0.0010 |
| 631 |
ROTATOR CUFF SYNDROME |
13 |
0.0010 |
| 632 |
BACK INJURY |
11 |
0.0010 |
| 633 |
FACIAL PAIN |
9 |
0.0010 |
| 634 |
HIATUS HERNIA |
13 |
0.0010 |
| 635 |
WOUND |
28 |
0.0010 |
| 636 |
HYPOTONIA |
10 |
0.0010 |
| 637 |
DRY EYE |
50 |
0.0010 |
| 638 |
BLOOD TEST ABNORMAL |
14 |
0.0010 |
| 639 |
PRODUCT ADMINISTRATION ERROR |
20 |
0.0010 |
| 640 |
BLOOD PRESSURE INCREASED |
151 |
0.0010 |
| 641 |
EATING DISORDER |
21 |
0.0010 |
| 642 |
HERNIA |
19 |
0.0010 |
| 643 |
DRUG INEFFECTIVE |
1295 |
0.0010 |
| 644 |
TOOTH ABSCESS |
10 |
0.0010 |
| 645 |
PAIN IN EXTREMITY |
289 |
0.0010 |
| 646 |
SKIN INFECTION |
11 |
0.0010 |
| 647 |
BRAIN NEOPLASM |
9 |
0.0010 |
| 648 |
RESPIRATORY ARREST |
27 |
0.0010 |
| 649 |
IMPAIRED QUALITY OF LIFE |
14 |
0.0010 |
| 650 |
SURGERY |
57 |
0.0010 |
| 651 |
MALIGNANT MELANOMA |
13 |
0.0010 |
| 652 |
DRUG LEVEL INCREASED |
16 |
0.0010 |
| 653 |
SINUS CONGESTION |
13 |
0.0010 |
| 654 |
BASAL CELL CARCINOMA |
15 |
0.0010 |
| 655 |
TUBULOINTERSTITIAL NEPHRITIS |
18 |
0.0010 |
| 656 |
PULMONARY HYPERTENSION |
20 |
0.0010 |
| 657 |
CONTRAINDICATED PRODUCT ADMINISTERED |
29 |
0.0010 |
| 658 |
HOT FLUSH |
72 |
0.0010 |
| 659 |
POISONING DELIBERATE |
9 |
0.0009 |
| 660 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 661 |
ANGER |
32 |
0.0009 |
| 662 |
EMOTIONAL DISORDER |
29 |
0.0009 |
| 663 |
EXTRA DOSE ADMINISTERED |
38 |
0.0009 |
| 664 |
DRUG WITHDRAWAL SYNDROME |
82 |
0.0009 |
| 665 |
BLINDNESS |
38 |
0.0009 |
| 666 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
168 |
0.0009 |
| 667 |
HYPOAESTHESIA ORAL |
14 |
0.0009 |
| 668 |
RENAL IMPAIRMENT |
78 |
0.0009 |
| 669 |
ACUTE KIDNEY INJURY |
141 |
0.0009 |
| 670 |
DEVICE USE ERROR |
32 |
0.0009 |
| 671 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
43 |
0.0009 |
| 672 |
CARDIAC ARREST |
76 |
0.0009 |
| 673 |
SEASONAL ALLERGY |
13 |
0.0009 |
| 674 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
65 |
0.0009 |
| 675 |
GASTRITIS |
24 |
0.0009 |
| 676 |
MIGRAINE |
87 |
0.0009 |
| 677 |
BACTERIAL INFECTION |
17 |
0.0009 |
| 678 |
DRUG EFFECT DECREASED |
49 |
0.0009 |
| 679 |
UPPER RESPIRATORY TRACT INFECTION |
42 |
0.0009 |
| 680 |
HEART RATE INCREASED |
90 |
0.0009 |
| 681 |
MUSCULOSKELETAL CHEST PAIN |
14 |
0.0009 |
| 682 |
EYE PAIN |
51 |
0.0009 |
| 683 |
INFLUENZA LIKE ILLNESS |
74 |
0.0009 |
| 684 |
INFECTION |
129 |
0.0009 |
| 685 |
DRUG INTOLERANCE |
86 |
0.0009 |
| 686 |
INFLUENZA |
98 |
0.0009 |
| 687 |
SKIN HAEMORRHAGE |
13 |
0.0009 |
| 688 |
INTENTIONAL DOSE OMISSION |
25 |
0.0009 |
| 689 |
NAUSEA |
694 |
0.0009 |
| 690 |
IMMUNODEFICIENCY |
13 |
0.0009 |
| 691 |
BURNING SENSATION |
61 |
0.0009 |
| 692 |
SKIN DISORDER |
29 |
0.0009 |
| 693 |
NIGHT SWEATS |
28 |
0.0009 |
| 694 |
NERVOUS SYSTEM DISORDER |
27 |
0.0009 |
| 695 |
BACK DISORDER |
14 |
0.0009 |
| 696 |
WEIGHT FLUCTUATION |
9 |
0.0009 |
| 697 |
MASS |
12 |
0.0009 |
| 698 |
SWELLING |
80 |
0.0009 |
| 699 |
THERAPY INTERRUPTED |
61 |
0.0009 |
| 700 |
C-REACTIVE PROTEIN INCREASED |
31 |
0.0009 |
| 701 |
SUDDEN DEATH |
9 |
0.0008 |
| 702 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
22 |
0.0008 |
| 703 |
INCREASED APPETITE |
16 |
0.0008 |
| 704 |
SKIN CANCER |
18 |
0.0008 |
| 705 |
CLOSTRIDIUM DIFFICILE INFECTION |
18 |
0.0008 |
| 706 |
ARRHYTHMIA |
39 |
0.0008 |
| 707 |
GASTROENTERITIS |
12 |
0.0008 |
| 708 |
NO THERAPEUTIC RESPONSE |
10 |
0.0008 |
| 709 |
ORAL HERPES |
16 |
0.0008 |
| 710 |
COMA |
39 |
0.0008 |
| 711 |
SCAR |
14 |
0.0008 |
| 712 |
PRODUCTIVE COUGH |
39 |
0.0008 |
| 713 |
EXPIRED PRODUCT ADMINISTERED |
27 |
0.0008 |
| 714 |
VIRAL INFECTION |
27 |
0.0008 |
| 715 |
INTENTIONAL PRODUCT MISUSE |
71 |
0.0008 |
| 716 |
TENDON RUPTURE |
10 |
0.0008 |
| 717 |
SINUS DISORDER |
16 |
0.0008 |
| 718 |
IMPAIRED GASTRIC EMPTYING |
11 |
0.0008 |
| 719 |
DISCOMFORT |
49 |
0.0008 |
| 720 |
BLOOD POTASSIUM INCREASED |
13 |
0.0008 |
| 721 |
HYPOXIA |
28 |
0.0008 |
| 722 |
DERMATITIS ALLERGIC |
10 |
0.0008 |
| 723 |
GASTROINTESTINAL DISORDER |
71 |
0.0008 |
| 724 |
COMPLETED SUICIDE |
66 |
0.0008 |
| 725 |
ATRIAL FIBRILLATION |
77 |
0.0008 |
| 726 |
PRODUCT AVAILABILITY ISSUE |
18 |
0.0008 |
| 727 |
FLUID RETENTION |
40 |
0.0008 |
| 728 |
HEADACHE |
493 |
0.0008 |
| 729 |
BRONCHITIS |
58 |
0.0008 |
| 730 |
ABDOMINAL DISCOMFORT |
131 |
0.0008 |
| 731 |
BLINDNESS UNILATERAL |
11 |
0.0008 |
| 732 |
NEUROPATHY PERIPHERAL |
74 |
0.0008 |
| 733 |
DRUG DOSE OMISSION |
128 |
0.0008 |
| 734 |
RHINORRHOEA |
50 |
0.0008 |
| 735 |
NASOPHARYNGITIS |
142 |
0.0008 |
| 736 |
NODULE |
10 |
0.0008 |
| 737 |
CARDIO-RESPIRATORY ARREST |
32 |
0.0008 |
| 738 |
CIRCULATORY COLLAPSE |
13 |
0.0008 |
| 739 |
JOINT STIFFNESS |
20 |
0.0008 |
| 740 |
EYE DISORDER |
25 |
0.0008 |
| 741 |
WEIGHT INCREASED |
170 |
0.0008 |
| 742 |
ULCER |
12 |
0.0008 |
| 743 |
ACCIDENT |
9 |
0.0008 |
| 744 |
ABSCESS |
12 |
0.0008 |
| 745 |
HYPOTHYROIDISM |
24 |
0.0008 |
| 746 |
ELECTROCARDIOGRAM QT PROLONGED |
27 |
0.0007 |
| 747 |
RETCHING |
16 |
0.0007 |
| 748 |
DEVICE DEFECTIVE |
13 |
0.0007 |
| 749 |
PAIN |
459 |
0.0007 |
| 750 |
ACUTE MYOCARDIAL INFARCTION |
22 |
0.0007 |
| 751 |
ERECTILE DYSFUNCTION |
19 |
0.0007 |
| 752 |
BLOOD CREATININE INCREASED |
48 |
0.0007 |
| 753 |
OROPHARYNGEAL PAIN |
68 |
0.0007 |
| 754 |
DYSPEPSIA |
72 |
0.0007 |
| 755 |
CORONARY ARTERY OCCLUSION |
10 |
0.0007 |
| 756 |
GALLBLADDER DISORDER |
13 |
0.0007 |
| 757 |
ABDOMINAL DISTENSION |
76 |
0.0007 |
| 758 |
INJECTION SITE REACTION |
50 |
0.0007 |
| 759 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
10 |
0.0007 |
| 760 |
LOWER RESPIRATORY TRACT INFECTION |
33 |
0.0007 |
| 761 |
TOOTH EXTRACTION |
9 |
0.0007 |
| 762 |
FLATULENCE |
41 |
0.0007 |
| 763 |
SINUSITIS |
74 |
0.0007 |
| 764 |
MOOD SWINGS |
23 |
0.0007 |
| 765 |
INSURANCE ISSUE |
11 |
0.0007 |
| 766 |
DISEASE PROGRESSION |
85 |
0.0007 |
| 767 |
PRODUCT USE ISSUE |
135 |
0.0007 |
| 768 |
BLOOD UREA INCREASED |
12 |
0.0007 |
| 769 |
APHONIA |
10 |
0.0007 |
| 770 |
CARPAL TUNNEL SYNDROME |
10 |
0.0007 |
| 771 |
PRODUCT PRESCRIBING ERROR |
17 |
0.0007 |
| 772 |
THYROID DISORDER |
11 |
0.0007 |
| 773 |
HERPES ZOSTER |
41 |
0.0007 |
| 774 |
JOINT SWELLING |
86 |
0.0007 |
| 775 |
BLOOD CHOLESTEROL INCREASED |
33 |
0.0007 |
| 776 |
INJECTION SITE IRRITATION |
9 |
0.0007 |
| 777 |
INJECTION SITE MASS |
26 |
0.0007 |
| 778 |
THROAT TIGHTNESS |
19 |
0.0007 |
| 779 |
HEPATIC STEATOSIS |
13 |
0.0007 |
| 780 |
NASAL CONGESTION |
41 |
0.0007 |
| 781 |
PULMONARY EMBOLISM |
66 |
0.0007 |
| 782 |
DEVICE DELIVERY SYSTEM ISSUE |
19 |
0.0007 |
| 783 |
PARAESTHESIA ORAL |
10 |
0.0007 |
| 784 |
RENAL FAILURE |
92 |
0.0007 |
| 785 |
RESPIRATORY TRACT INFECTION |
18 |
0.0007 |
| 786 |
HYPERTHYROIDISM |
10 |
0.0007 |
| 787 |
CEREBROVASCULAR ACCIDENT |
117 |
0.0007 |
| 788 |
FUNGAL INFECTION |
23 |
0.0007 |
| 789 |
DEAFNESS |
18 |
0.0007 |
| 790 |
FRACTURE |
13 |
0.0007 |
| 791 |
RENAL DISORDER |
32 |
0.0007 |
| 792 |
INTENTIONAL OVERDOSE |
44 |
0.0007 |
| 793 |
PROCEDURAL PAIN |
19 |
0.0007 |
| 794 |
IMMUNE SYSTEM DISORDER |
9 |
0.0007 |
| 795 |
PULMONARY CONGESTION |
9 |
0.0007 |
| 796 |
ALOPECIA |
134 |
0.0007 |
| 797 |
EAR INFECTION |
18 |
0.0007 |
| 798 |
CHILLS |
79 |
0.0007 |
| 799 |
INTENTIONAL PRODUCT USE ISSUE |
59 |
0.0007 |
| 800 |
DYSPNOEA |
381 |
0.0007 |
| 801 |
ROAD TRAFFIC ACCIDENT |
28 |
0.0007 |
| 802 |
CHEST DISCOMFORT |
68 |
0.0007 |
| 803 |
OEDEMA |
36 |
0.0007 |
| 804 |
VISUAL ACUITY REDUCED |
22 |
0.0007 |
| 805 |
CARDIAC FAILURE |
53 |
0.0007 |
| 806 |
HYPOGLYCAEMIA |
32 |
0.0007 |
| 807 |
END STAGE RENAL DISEASE |
12 |
0.0007 |
| 808 |
PALPITATIONS |
77 |
0.0007 |
| 809 |
ACCIDENTAL OVERDOSE |
24 |
0.0007 |
| 810 |
PYREXIA |
227 |
0.0007 |
| 811 |
VOMITING |
308 |
0.0007 |
| 812 |
TINNITUS |
30 |
0.0007 |
| 813 |
HYPOACUSIS |
28 |
0.0006 |
| 814 |
RASH PRURITIC |
35 |
0.0006 |
| 815 |
HEPATIC ENZYME INCREASED |
44 |
0.0006 |
| 816 |
EYE SWELLING |
24 |
0.0006 |
| 817 |
PRODUCT USE IN UNAPPROVED INDICATION |
158 |
0.0006 |
| 818 |
OBESITY |
10 |
0.0006 |
| 819 |
INJECTION SITE BRUISING |
50 |
0.0006 |
| 820 |
METABOLIC ACIDOSIS |
20 |
0.0006 |
| 821 |
OFF LABEL USE |
546 |
0.0006 |
| 822 |
OXYGEN SATURATION DECREASED |
35 |
0.0006 |
| 823 |
SEPTIC SHOCK |
27 |
0.0006 |
| 824 |
MUSCULOSKELETAL PAIN |
32 |
0.0006 |
| 825 |
DYSPNOEA EXERTIONAL |
23 |
0.0006 |
| 826 |
SUICIDE ATTEMPT |
37 |
0.0006 |
| 827 |
ARTHRITIS |
48 |
0.0006 |
| 828 |
GASTROOESOPHAGEAL REFLUX DISEASE |
49 |
0.0006 |
| 829 |
IMPAIRED WORK ABILITY |
13 |
0.0006 |
| 830 |
VENTRICULAR TACHYCARDIA |
10 |
0.0006 |
| 831 |
PHOTOSENSITIVITY REACTION |
10 |
0.0006 |
| 832 |
CHRONIC KIDNEY DISEASE |
46 |
0.0006 |
| 833 |
CHEST PAIN |
112 |
0.0006 |
| 834 |
ABDOMINAL PAIN UPPER |
124 |
0.0006 |
| 835 |
AGEUSIA |
15 |
0.0006 |
| 836 |
LIP SWELLING |
20 |
0.0006 |
| 837 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
13 |
0.0006 |
| 838 |
LEUKOPENIA |
30 |
0.0006 |
| 839 |
SWELLING FACE |
39 |
0.0006 |
| 840 |
THERAPEUTIC RESPONSE DECREASED |
36 |
0.0006 |
| 841 |
CARDIAC DISORDER |
55 |
0.0006 |
| 842 |
DEEP VEIN THROMBOSIS |
38 |
0.0006 |
| 843 |
TOOTH DISORDER |
13 |
0.0006 |
| 844 |
SKIN LESION |
16 |
0.0006 |
| 845 |
LYMPHOMA |
9 |
0.0006 |
| 846 |
PULMONARY OEDEMA |
26 |
0.0006 |
| 847 |
IMPAIRED HEALING |
19 |
0.0006 |
| 848 |
LABORATORY TEST ABNORMAL |
17 |
0.0006 |
| 849 |
FIBROMYALGIA |
14 |
0.0006 |
| 850 |
LOCAL SWELLING |
10 |
0.0006 |
| 851 |
ILLNESS |
59 |
0.0006 |
| 852 |
CYANOSIS |
9 |
0.0006 |
| 853 |
THROMBOSIS |
46 |
0.0006 |
| 854 |
PRODUCT USE COMPLAINT |
9 |
0.0006 |
| 855 |
INJURY |
40 |
0.0006 |
| 856 |
EAR PAIN |
11 |
0.0006 |
| 857 |
HAEMORRHOIDS |
11 |
0.0006 |
| 858 |
WHITE BLOOD CELL COUNT DECREASED |
61 |
0.0006 |
| 859 |
INFLAMMATION |
29 |
0.0006 |
| 860 |
ERYTHEMA |
115 |
0.0006 |
| 861 |
DISABILITY |
11 |
0.0006 |
| 862 |
ABDOMINAL PAIN LOWER |
14 |
0.0006 |
| 863 |
TOOTHACHE |
10 |
0.0006 |
| 864 |
LUNG DISORDER |
27 |
0.0006 |
| 865 |
INTENTIONAL SELF-INJURY |
11 |
0.0005 |
| 866 |
SWOLLEN TONGUE |
17 |
0.0005 |
| 867 |
DIVERTICULITIS |
15 |
0.0005 |
| 868 |
ARTHROPATHY |
30 |
0.0005 |
| 869 |
CONJUNCTIVITIS |
10 |
0.0005 |
| 870 |
RESPIRATORY DISORDER |
16 |
0.0005 |
| 871 |
CANDIDA INFECTION |
9 |
0.0005 |
| 872 |
LACRIMATION INCREASED |
16 |
0.0005 |
| 873 |
DERMATITIS |
11 |
0.0005 |
| 874 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
13 |
0.0005 |
| 875 |
HYPERGLYCAEMIA |
19 |
0.0005 |
| 876 |
PULMONARY FIBROSIS |
10 |
0.0005 |
| 877 |
HYPOKALAEMIA |
24 |
0.0005 |
| 878 |
OVERDOSE |
112 |
0.0005 |
| 879 |
RENAL FAILURE ACUTE |
22 |
0.0005 |
| 880 |
BLISTER |
29 |
0.0005 |
| 881 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
104 |
0.0005 |
| 882 |
CARDIOVASCULAR DISORDER |
13 |
0.0005 |
| 883 |
INCORRECT DOSE ADMINISTERED |
115 |
0.0005 |
| 884 |
ARTHRALGIA |
209 |
0.0005 |
| 885 |
HAEMOPTYSIS |
14 |
0.0005 |
| 886 |
COLITIS |
19 |
0.0005 |
| 887 |
INJECTION SITE ERYTHEMA |
62 |
0.0005 |
| 888 |
PRURITUS |
191 |
0.0005 |
| 889 |
APPLICATION SITE ERYTHEMA |
13 |
0.0005 |
| 890 |
TASTE DISORDER |
10 |
0.0005 |
| 891 |
DIABETES MELLITUS |
37 |
0.0005 |
| 892 |
HYPERKALAEMIA |
17 |
0.0005 |
| 893 |
MYALGIA |
82 |
0.0005 |
| 894 |
ABDOMINAL PAIN |
112 |
0.0005 |
| 895 |
HYPERSENSITIVITY |
89 |
0.0005 |
| 896 |
GASTRIC DISORDER |
16 |
0.0005 |
| 897 |
LIVER FUNCTION TEST INCREASED |
10 |
0.0005 |
| 898 |
SKIN ULCER |
12 |
0.0005 |
| 899 |
PRURITUS GENERALISED |
10 |
0.0005 |
| 900 |
FAECES DISCOLOURED |
10 |
0.0005 |
| 901 |
GLOSSODYNIA |
10 |
0.0004 |
| 902 |
ASTHMA |
50 |
0.0004 |
| 903 |
HAEMOGLOBIN DECREASED |
45 |
0.0004 |
| 904 |
HAEMATURIA |
15 |
0.0004 |
| 905 |
BLOOD GLUCOSE DECREASED |
21 |
0.0004 |
| 906 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
11 |
0.0004 |
| 907 |
CARDIAC FAILURE CONGESTIVE |
35 |
0.0004 |
| 908 |
SHOCK |
10 |
0.0004 |
| 909 |
HAEMATEMESIS |
11 |
0.0004 |
| 910 |
INJECTION SITE PRURITUS |
29 |
0.0004 |
| 911 |
DRUG ABUSE |
36 |
0.0004 |
| 912 |
RASH |
186 |
0.0004 |
| 913 |
LYMPHADENOPATHY |
15 |
0.0004 |
| 914 |
ALANINE AMINOTRANSFERASE INCREASED |
26 |
0.0004 |
| 915 |
ANAEMIA |
80 |
0.0004 |
| 916 |
ANHEDONIA |
11 |
0.0004 |
| 917 |
DIARRHOEA |
269 |
0.0004 |
| 918 |
LIVER FUNCTION TEST ABNORMAL |
12 |
0.0004 |
| 919 |
BLOOD PRESSURE SYSTOLIC INCREASED |
8 |
0.0004 |
| 920 |
PAIN OF SKIN |
11 |
0.0004 |
| 921 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
21 |
0.0004 |
| 922 |
OCULAR HYPERAEMIA |
19 |
0.0004 |
| 923 |
PRODUCT SUBSTITUTION ISSUE |
23 |
0.0004 |
| 924 |
DISEASE RECURRENCE |
19 |
0.0004 |
| 925 |
HEPATIC FAILURE |
12 |
0.0004 |
| 926 |
CORONARY ARTERY DISEASE |
12 |
0.0004 |
| 927 |
NEUTROPHIL COUNT DECREASED |
16 |
0.0004 |
| 928 |
HAEMORRHAGE |
41 |
0.0004 |
| 929 |
OSTEOPOROSIS |
16 |
0.0004 |
| 930 |
URTICARIA |
65 |
0.0004 |
| 931 |
EYE IRRITATION |
22 |
0.0004 |
| 932 |
MYOCARDIAL INFARCTION |
66 |
0.0004 |
| 933 |
DYSGEUSIA |
28 |
0.0004 |
| 934 |
HEPATIC FUNCTION ABNORMAL |
14 |
0.0004 |
| 935 |
EPISTAXIS |
28 |
0.0004 |
| 936 |
LIVER INJURY |
9 |
0.0004 |
| 937 |
BREAST CANCER |
34 |
0.0004 |
| 938 |
DRUG ADMINISTRATION ERROR |
11 |
0.0004 |
| 939 |
TYPE 2 DIABETES MELLITUS |
12 |
0.0004 |
| 940 |
RASH ERYTHEMATOUS |
17 |
0.0004 |
| 941 |
PAIN IN JAW |
10 |
0.0004 |
| 942 |
APPLICATION SITE PRURITUS |
8 |
0.0004 |
| 943 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
9 |
0.0003 |
| 944 |
RECTAL HAEMORRHAGE |
15 |
0.0003 |
| 945 |
ANGINA PECTORIS |
10 |
0.0003 |
| 946 |
GASTROINTESTINAL HAEMORRHAGE |
29 |
0.0003 |
| 947 |
THROMBOCYTOPENIA |
38 |
0.0003 |
| 948 |
TREATMENT FAILURE |
28 |
0.0003 |
| 949 |
EMOTIONAL DISTRESS |
40 |
0.0003 |
| 950 |
PLEURAL EFFUSION |
20 |
0.0003 |
| 951 |
INFUSION RELATED REACTION |
21 |
0.0003 |
| 952 |
RED BLOOD CELL COUNT DECREASED |
9 |
0.0003 |
| 953 |
MATERNAL EXPOSURE DURING PREGNANCY |
28 |
0.0003 |
| 954 |
SKIN EXFOLIATION |
26 |
0.0003 |
| 955 |
HAEMATOCHEZIA |
17 |
0.0003 |
| 956 |
PRODUCT ADHESION ISSUE |
11 |
0.0003 |
| 957 |
MEDICATION ERROR |
17 |
0.0003 |
| 958 |
OSTEONECROSIS |
10 |
0.0003 |
| 959 |
WHEEZING |
18 |
0.0003 |
| 960 |
ASPARTATE AMINOTRANSFERASE INCREASED |
16 |
0.0003 |
| 961 |
INJECTION SITE SWELLING |
22 |
0.0003 |
| 962 |
DEVICE MALFUNCTION |
20 |
0.0003 |
| 963 |
PANCREATITIS |
15 |
0.0003 |
| 964 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
10 |
0.0003 |
| 965 |
BONE PAIN |
15 |
0.0003 |
| 966 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
9 |
0.0003 |
| 967 |
INJECTION SITE HAEMORRHAGE |
20 |
0.0003 |
| 968 |
ABORTION SPONTANEOUS |
10 |
0.0002 |
| 969 |
ECZEMA |
13 |
0.0002 |
| 970 |
INJECTION SITE PAIN |
75 |
0.0002 |
| 971 |
DRY SKIN |
32 |
0.0002 |
| 972 |
PRODUCT QUALITY ISSUE |
32 |
0.0002 |
| 973 |
STOMATITIS |
14 |
0.0002 |
| 974 |
NO ADVERSE EVENT |
41 |
0.0002 |
| 975 |
LIVER DISORDER |
10 |
0.0002 |
| 976 |
PLATELET COUNT DECREASED |
24 |
0.0002 |
| 977 |
SKIN BURNING SENSATION |
16 |
0.0002 |
| 978 |
NEUTROPENIA |
30 |
0.0002 |
| 979 |
VAGINAL HAEMORRHAGE |
9 |
0.0002 |
| 980 |
BLOOD GLUCOSE INCREASED |
35 |
0.0002 |
| 981 |
NEOPLASM MALIGNANT |
12 |
0.0002 |
| 982 |
BLADDER CANCER |
10 |
0.0002 |
| 983 |
PANCYTOPENIA |
9 |
0.0002 |
| 984 |
ACNE |
12 |
0.0002 |
| 985 |
DEVICE EXPULSION |
10 |
0.0002 |
| 986 |
PROSTATE CANCER |
12 |
0.0001 |
| 987 |
PRODUCT STORAGE ERROR |
12 |
0.0001 |
| 988 |
FOETAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 989 |
RHEUMATOID ARTHRITIS |
15 |
0.0001 |
| 990 |
PSORIASIS |
15 |
0.0001 |
| 991 |
MALIGNANT NEOPLASM PROGRESSION |
11 |
0.0001 |
| 992 |
DRUG DEPENDENCE |
15 |
0.0001 |